Carlo Selmi Principal Investigator View More
- AddressVia A. Manzoni 56, 20089 Rozzano, Milan, Italy
- Telephone+39 02 8224-5129 / 6643
- Fax+39 02 8224-5191 / 4590
Dr. Selmi received his MD in 1998 and his PhD in Internal Medicine in 2002, both from the University of Milan. He was appointed Assistant Professor by the same University for Internal Medicine in 2006 and for Rheumatology in 2011. In 2004 he was awarded the Young Researcher prize by the Italian Society of Internal Medicine and in 2005 the Young Investigator Award by the Aesku-Kipp Foundation. Dr. Selmi was a post-doctoral researcher between august 2001 and december 2004 at the Division of Rheumatology, Allergy, and Clinical Immunology of the University of California, Davis School of Medicine. Since July 2005, he was appointed Assistant Adjunct Professor of Medicine by the same Division at UC Davis.
Carlo Selmi currently leads the Rheumatology and Clinical Immunology Unit at Humanitas research hospital. At Humanitas he leads a young group of physician scientists with wide research and clinical expertise, including periods working at foreign institutions. The team holds dedicated clinics for rheumatoid arthritis, spondiloarthritis, connective tissue disease with dedicated clinics for systemic sclerosis and systemic lupus erythematosus, and is active in articular ultrasound, videocapillaroscopy, arthrocenthesis and intra-articular injections.
Working in research since 2003 he has coauthored over 260 peer-reviewed publications with a Google Scholar H index of 62 and a total impact factor exceeding 1600 points.
His research track is dedicated to organ-specific and systemic autoimmune and chronic inflammatory diseases, including the clinical epidemiology and pathogenetic mechanisms of autoimmune liver disease, connective tissue disease (particularly systemic sclerosis), and psoriatic arthritis. His work has been funded by the National Institutes of Health, American Liver Foundation, American Scleroderma Foundation, Italian Ministry of Health, Italian Ministry of Foreign Affairs, and the Lilly Research Foundation.
Biomarkers for autoimmune and chronic inflammatory diseases, particularly novel serum autoantibodies and epigenetic changes. This interest is mirrored by the collection over the years of series of monozygotic twins both discordant and concordant for paradigmatic conditions (i.e. psoriasis and psoriatic arthritis, systemic sclerosis, autoimmune liver disease, inflammatory bowel disease) and by the use of immunoprecipitation and epigenome approaches.
Post-translational modifications of established and proposed autoantigens in rheumatoid arthritis and in psoriatic disease
Clinical epidemiology of autoimmunity and chronic inflammatory disease with large population-based case-finding studies for serum autoantibodies and the analysys of real-life administrative databases.
Carlo Selmi Publications
Selected Publications: 20-25 publications listed in details with all the contributing authors, title of the papers, journal, dates. Agmon-Levin N., Ram M., Barzilai O., Porat-Katz B.S., Parikman R., SELMI C., ...